Education
About Us
Working with TipRanks
Follow Us
Biofil Chemicals & Pharmaceuticals Ltd. (IN:BIOFILCHEM)
:BIOFILCHEM
Total Valuation
Biofil Chemicals & Pharmaceuticals Ltd. has a market cap or net worth of ₹748.59M. The enterprise value is ₹760.93M.
Market Cap₹748.59M
Enterprise Value₹760.93M
Share Statistics
Biofil Chemicals & Pharmaceuticals Ltd. has 16,273,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,273,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biofil Chemicals & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 1.81%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.81%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee12.85M
Profits Per Employee283.15K
Employee Count26
Asset Turnover0.66
Inventory Turnover9.37
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio141.5
PS Ratio0.00
PB Ratio4.10
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-3.41
Income Statement
In the last 12 months, Biofil Chemicals & Pharmaceuticals Ltd. had revenue of 334.02M and earned 5.58M in profits. Earnings per share was 0.34.
Revenue334.02M
Gross Profit20.91M
Operating Income4.68M
Pretax Income7.36M
Net Income5.58M
EBITDA11.53M
Earnings Per Share (EPS)0.34
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Biofil Chemicals & Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.26
52-Week Price Change-20.79%
50-Day Moving Average47.77
200-Day Moving Average54.61
Relative Strength Index (RSI)53.61
Average Volume (3m)3.77K
Important Dates
Biofil Chemicals & Pharmaceuticals Ltd. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Biofil Chemicals & Pharmaceuticals Ltd. as a current ratio of 1.34, with Debt / Equity ratio of 2.51%
Current Ratio1.34
Quick Ratio1.23
Debt to Market Cap0.00
Net Debt to EBITDA0.29
Interest Coverage Ratio12.68
Taxes
In the past 12 months, Biofil Chemicals & Pharmaceuticals Ltd. has paid 1.78M in taxes.
Income Tax1.78M
Effective Tax Rate0.24
Enterprise Valuation
Biofil Chemicals & Pharmaceuticals Ltd. EV to EBITDA ratio is 0.29, with an EV/FCF ratio of -0.17.
EV to Sales0.01
EV to EBITDA0.29
EV to Free Cash Flow-0.17
EV to Operating Cash Flow-0.18
Balance Sheet
Biofil Chemicals & Pharmaceuticals Ltd. has ₹2.20M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹2.20M billion.
Cash & Marketable Securities₹2.20M
Total Debt₹0.00
Net Cash-₹2.20M
Net Cash Per Share-₹0.14
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 6.62%, with operating margin of 1.40%, and net profit margin of 1.67%.
Gross Margin6.62%
Operating Margin1.40%
Pretax Margin2.20%
Net Profit Margin1.67%
EBITDA Margin3.45%
EBIT Margin2.31%
Analyst Forecast
The average price target for Biofil Chemicals & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-16.57%
EPS Growth Forecast-21.92%